NYSE: ELV | Healthcare / Healthcare Plans / USA |
447.10 | -3.73 | -0.83% | Vol 806.19K | 1Y Perf -2.60% |
Sep 22nd, 2023 16:00 DELAYED |
BID | 438.76 | ASK | 453.19 | ||
Open | 448.23 | Previous Close | 450.83 | ||
Pre-Market | - | After-Market | 447.09 | ||
- - | -0.01 0.00% |
Target Price | 568.44 | Analyst Rating | Strong Buy 1.22 | |
Potential % | 27.14 | Finscreener Ranking | — - | |
Insiders Trans % 3/6/12 mo. | -100/-100/-100 | Value Ranking | ★★ 46.85 | |
Insiders Value % 3/6/12 mo. | -100/-100/-100 | Growth Ranking | — - | |
Insiders Shares Cnt. % 3/6/12 mo. | -100/-100/-100 | Income Ranking | ★★ 39.44 | |
Price Range Ratio 52W % | 25.52 | Earnings Rating | — | |
Market Cap | 105.36B | Earnings Date | 18th Oct 2023 | |
Alpha | 0.01 | Standard Deviation | 0.08 | |
Beta | 0.84 |
Today's Price Range 446.16451.57 | 52W Range 412.00549.52 | 5 Year PE Ratio Range 9.3026.20 |
Summary:
Sell
Technical Indicators: | Neutral |
Moving Averages: | Strong Sell |
Performance | |||
---|---|---|---|
1 Week | 1.17% | ||
1 Month | -2.77% | ||
3 Months | -0.73% | ||
6 Months | 0.18% | ||
1 Year | -2.60% | ||
3 Years | 85.70% | ||
5 Years | 71.59% | ||
10 Years | 509.36% |
Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
ROE (5Y Avg) | 10.29 | |||
ROE last 12 Months | 17.32 | |||
ROA (5Y Avg) | 3.11 | |||
ROA last 12 Months | 6.18 | |||
ROC (5Y Avg) | - | |||
ROC last 12 Months | - | |||
Return on invested Capital Q | - | |||
Return on invested Capital Y | - | |||
Assets Turnover | 0.50 | |||
Receivables Turnover | - |
Valuation | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
18.60 | ||||
3.16 | ||||
0.96 | ||||
10.00 | ||||
15.10 | ||||
41.32 | ||||
105.73 | ||||
147.24 | ||||
128.46B | ||||
Forward PE | - | |||
PEG | - |
Financial Strength | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
- | ||||
- | ||||
0.37 | ||||
0.66 | ||||
10.80 | ||||
Leverage Ratio | 2.80 |
Profitability | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
- | ||||
5.80 | ||||
- | ||||
4.90 | ||||
4.34 |
Revenue | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
116.67B | ||||
488.50 | ||||
- | ||||
- |
Dividends | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
1.09 | ||||
5.12 | ||||
13.94 | ||||
11.77 | ||||
Payout ratio | - |
Earnings History | Estimate | Reported | Surprise % |
---|---|---|---|
Q02 2023 | 8.82 | 9.04 | 2.49 |
Q01 2023 | 9.26 | 9.46 | 2.16 |
Q04 2022 | 5.20 | 5.23 | 0.58 |
Q03 2022 | 7.10 | 7.53 | 6.06 |
Q02 2022 | 7.72 | 8.04 | 4.15 |
Q01 2022 | 7.81 | 8.25 | 5.63 |
Q04 2021 | 5.11 | 5.14 | 0.59 |
Q03 2021 | 6.35 | 6.79 | 6.93 |
Earnings Per End | Estimate | Revision % | Trend |
---|---|---|---|
- | - | - | - |
- | - | - | - |
- | - | - | - |
- | - | - | - |
Next Report Date | 18th Oct 2023 |
Estimated EPS Next Report | 8.45 |
Estimates Count | 12 |
EPS Growth Next 5 Years % | - |
Volume Overview | |
---|---|
Volume | 806.19K |
Shares Outstanding | 235.65K |
Shares Float | 235.23M |
Trades Count | 21.34K |
Dollar Volume | 361.47M |
Avg. Volume | 1.10M |
Avg. Weekly Volume | 1.16M |
Avg. Monthly Volume | 995.86K |
Avg. Quarterly Volume | 1.15M |
Elevance Health Inc. (NYSE: ELV) stock closed at 447.1 per share at the end of the most recent trading day (a -0.83% change compared to the prior day closing price) with a volume of 806.19K shares and market capitalization of 105.36B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Plans industry, Healthcare sector and employs 98200 people. Elevance Health Inc. CEO is Gail Koziara Boudreaux.
The one-year performance of Elevance Health Inc. stock is -2.6%, while year-to-date (YTD) performance is -12.84%. ELV stock has a five-year performance of 71.59%. Its 52-week range is between 412 and 549.52, which gives ELV stock a 52-week price range ratio of 25.52%
Elevance Health Inc. currently has a PE ratio of 18.60, a price-to-book (PB) ratio of 3.16, a price-to-sale (PS) ratio of 0.96, a price to cashflow ratio of 10.00, a PEG ratio of -, a ROA of 6.18%, a ROC of -% and a ROE of 17.32%. The company’s profit margin is 4.34%, its EBITDA margin is -%, and its revenue ttm is $116.67 Billion , which makes it $488.49 revenue per share.
Of the last four earnings reports from Elevance Health Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $8.45 for the next earnings report. Elevance Health Inc.’s next earnings report date is 18th Oct 2023.
The consensus rating of Wall Street analysts for Elevance Health Inc. is Strong Buy (1.22), with a target price of $568.44, which is +27.14% compared to the current price. The earnings rating for Elevance Health Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Elevance Health Inc. has a dividend yield of 1.09% with a dividend per share of $5.12 and a payout ratio of -%.
Elevance Health Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 42.30, ATR14 : 8.48, CCI20 : 6.70, Chaikin Money Flow : -0.09, MACD : -3.39, Money Flow Index : 49.45, ROC : 0.25, RSI : 47.06, STOCH (14,3) : 60.28, STOCH RSI : 0.74, UO : 52.15, Williams %R : -39.72), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Elevance Health Inc. in the last 12-months were: Charles Morgan Kendrick (Sold 2 314 shares of value $1 069 577 ), Dixon Robert L JR (Sold 310 shares of value $147 780 ), Gloria M. McCarthy (Sold 15 098 shares of value $6 714 978 ), Kendrick Charles (Sold 2 314 shares of value $1 069 577 )
Analyst Ratings | Current | 1 M ago | 3 M ago |
---|---|---|---|
Strong Buy | |||
Moderate Buy | |||
Hold | |||
Moderate Sell | |||
Strong Sell | |||
Summary Rating | Strong Buy | Strong Buy | Strong Buy |
Anthem remains one of the leading health insurers in the U.S., providing medical benefits to roughly 45 million medical members. The company offers employer, individual, and government-sponsored coverage plans. Anthem differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Anthem's reach expands beyond those states through government-sponsored programs such as Medicaid, too.
CEO: Gail Koziara Boudreaux
Telephone: +1 800 331-1476
Address: 220 Virginia Avenue, Indianapolis 46204, IN, US
Number of employees: 98 200
Wed, 09 Aug 2023 07:32 GMT Analysts Offer Insights on Healthcare Companies: Sangamo Biosciences (SGMO), Elevance Health (ELV) and Eli Lilly & Co (LLY)
- TipRanks. All rights reserved.Wed, 19 Jul 2023 13:10 GMT Analysts Offer Insights on Healthcare Companies: Elevance Health (ELV) and BeiGene (BGNE)
- TipRanks. All rights reserved.Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
All rights reserved. Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. NYSE/NYSE MKT (AMEX) data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless otherwise indicated. Copyright © 2023. All market data is provided by Quotemedia.com. Futures: at least a 10 minute delay. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer.
General partner of Finscreener is SLOVAKODATA, a.s.
Don´t have an account? Register
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.